Skip to page content
Official US Government Icon

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure Site Icon

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

The latest general information on the Coronavirus (COVID-19) is available on For FAA-specific COVID-19 resources, please visit
United States Department of TransportationUnited States Department of Transportation

Guide for Aviation Medical Examiners

Pharmaceuticals (Therapeutic Medications)

  1. Code of Federal Regulations:

  2. Medical History: Item 18.h., High or low blood pressure.

  3. Aeromedical Decision Considerations:

  4. Protocol: N/A. See Hypertension Worksheet (PDF).

  5. Pharmaceutical Considerations
    • Seven-day (7) no fly/ground trial is required when starting a new hypertension (HTN) medication to verify no side effects.
    • AME should issue (if otherwise qualified) if the airmen is on 3 or fewer medications.
    • Uses of beta-adrenergic blockers ARE allowed with insulin, meglitinides, or sulfonylureas.
  6. Acceptable HTN Medications
    (when certification criteria are met)
    Alpha adrenergic blockers Calcium channel blockers
    Angiotensin converting enzyme (ACE) inhibitors Direct renin inhibitors
    Angiotensin II receptor antagonists (ARBs) Direct vasodilators
    Beta-adrenergic blockers Diuretics
    UNACCEPTABLE HTN Medications
    (as a single agent or in any combination product)
    Clonidine (ex. Catapres/Clorpres)
    Nitrates (ex. nitroglycerin/isosorbide dinitrate/isosorbide mononitrate)

Page last modified: